Carcinoma, Intraductal, Noninfiltrating clinical trials at UCSF

1 research study open to eligible people

Carcinoma, intraductal, noninfiltrating is a non-spreading breast cancer found in the milk ducts. UCSF is conducting trials to observe the impact of immunotherapy. The research looks at immune system changes after a brief exposure to the treatment.

Showing trials for

  • Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

    open to eligible females ages 18 years and up

    This is a study to investigate the change in the immune microenvironment of high risk ductal carcinoma in situ (DCIS) after short term exposure to immunotherapy.

    San Francisco, California

Our lead scientists for Carcinoma, Intraductal, Noninfiltrating research studies include .

Last updated: